MedTrace Logo

Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3

NCT04399265 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-08-16

No results posted yet for this study

Summary

This study evaluates the effectiveness of oral trehalose in alleviating the neuropathological and motor behaviour deficits among patients with SCA3. A total of 40 participants with SCA3 will be recruited, with 20 participants to be administered with trehalose while another 20 participants to be administered with a maltose placebo.

Conditions

  • Spinocerebellar Ataxia Type 3

Interventions

DIETARY_SUPPLEMENT

Trehalose

A disaccharide sugar usually used as food preservative, but for this study it is given at a higher dose

DIETARY_SUPPLEMENT

Maltose

Maltose power

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Norlinah Mohamed Ibrahim, MRCP · National University of Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-24
Primary Completion
2023-05-30
Completion
2023-06-30

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04399265 on ClinicalTrials.gov